Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies. | Front Oncol | 2021 | 34778053 | PubTator, text mining | PubMed |
| Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis. | Dis Markers | 2021 | 34777635 | PubTator, text mining | PubMed |
| 3D-Printed Replica and Porcine Explants for Pre-Clinical Optimization of Endoscopic Tumor Treatment by Magnetic Targeting. | Cancers (Basel) | 2021 | 34771659 | PubTator, text mining | PubMed |
| The Transcriptome Characteristics of Severe Asthma From the Prospect of Co-Expressed Gene Modules. | Front Genet | 2021 | 34759961 | PubTator, text mining | PubMed |
| Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies. | Cell Death Dis | 2021 | 34750354 | PubTator, text mining | PubMed |
| Immunofluorescence-guided segmentation of three-dimensional features in micro-computed tomography datasets of human lung tissue. | R Soc Open Sci | 2021 | 34737879 | PubTator, text mining | PubMed |
| LncRNA Hmrhl regulates expression of cancer related genes in chronic myelogenous leukemia through chromatin association. | NAR Cancer | 2021 | 34734184 | PubTator, text mining | PubMed |
| Analysis of the Replication Mechanisms of the Human Papillomavirus Genomes. | Front Microbiol | 2021 | 34733254 | PubTator, text mining | PubMed |
| Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape. | Front Immunol | 2021 | 34721400 | PubTator, text mining | PubMed |
| Screening of characteristic genes in ulcerative colitis by integrating gene expression profiles. | BMC Gastroenterol | 2021 | 34717557 | PubTator, text mining | PubMed |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. | Cancer Cell | 2021 | 34715028 | PubTator, text mining | PubMed |
| Process research: compare and contrast the recovery-orientated strengths model of case management and usual community mental health care. | BMC Psychiatry | 2021 | 34711212 | PubTator, text mining | PubMed |
| Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis. | J Transl Med | 2021 | 34702300 | PubTator, text mining | PubMed |
| Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity? | Infect Dis Rep | 2021 | 34698153 | PubTator, text mining | PubMed |
| Modulation of Adaptive Immunity and Viral Infections by Ion Channels. | Front Physiol | 2021 | 34690811 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy. | Cells | 2021 | 34685540 | PubTator, text mining | PubMed |
| Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment. | Int J Mol Sci | 2021 | 34681859 | PubTator, text mining | PubMed |
| Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers. | Cancers (Basel) | 2021 | 34680295 | PubTator, text mining | PubMed |
| Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma. | Cancers (Basel) | 2021 | 34680209 | PubTator, text mining | PubMed |
| Improving Blood Flow Visualization of Recirculation Regions at Carotid Bulb in 4D Flow MRI Using Semi-Automatic Segmentation with ITK-SNAP. | Diagnostics (Basel) | 2021 | 34679588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=41